Cutaneous Lupus Erythematosus: IMVT-1402 Study

We are evaluating a new treatment for people with active cutaneous lupus erythematosus to see if it improves skin symptoms compared to a placebo. This study aims to assess its safety and effectiveness.

1-2 years Efficacy phase (II)Cost Reimbursement Investigational Medicines InjectionDermatologyRheumatology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Imeron

Imeron is a contrast dye used during CT scans and X-ray imaging to help doctors see organs and blood vessels.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Iomeprol

Iomeprol is a substance used to enhance visibility of blood vessels and organs during X-ray and CT scans.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Imvt-1402

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Iomeron

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Alexandrovska University Hospital

Clinic of Skin and Venereal diseases

Sofia, Bulgaria

Diagnostic Consultation Center XX-Sofia EOOD

Diagnostic Consultative Center XX - Sofia EOOD

Sofia, Bulgaria

Diagnostics And Consultation Center Convex Ltd.

Diagnostic Consultative Center

Sofia, Bulgaria

Sponsor: Immunovant Sciences GmbH

Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.